| 000 | 01649 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515071818.0 | ||
| 264 | 0 | _c20070911 | |
| 008 | 200709s 0 0 eng d | ||
| 022 | _a0001-706X | ||
| 024 | 7 |
_a10.1016/j.actatropica.2007.04.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRodrigues, Alex Miranda | |
| 245 | 0 | 0 |
_aPossible cardioprotective effect of angiotensin-converting enzyme inhibitors during treatment of American tegumentary leishmaniasis with meglumine antimoniate. _h[electronic resource] |
| 260 |
_bActa tropica _cMay 2007 |
||
| 300 |
_a113-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xadverse effects |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeishmania _xgrowth & development |
| 650 | 0 | 4 |
_aLeishmaniasis, Cutaneous _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeglumine _xadverse effects |
| 650 | 0 | 4 | _aMeglumine Antimoniate |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aHueb, Márcia | |
| 700 | 1 | _aNery, Andréia Ferreira | |
| 700 | 1 | _aFontes, Cor Jesus Fernandes | |
| 773 | 0 |
_tActa tropica _gvol. 102 _gno. 2 _gp. 113-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.actatropica.2007.04.007 _zAvailable from publisher's website |
| 999 |
_c17094562 _d17094562 |
||